Skip to main content

Table 2 Projected incidence rates for cancer of major sites for the year 2018 (per 100,000)

From: Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018

Cancer site

Males

Females

 

Projected incidence rates

(R2)

Projected incidence rates

(R2)

 

2018

 

2018

 

Oropharyngeal

3.7

0.03

2.8

0.04

Esophagus

0.6

0.15

0.7

0.25

Stomach

9.3

0.21

7.7

0.08

Colon

17.1

0.26

10.9

0.03

Rectum

4.4

0.50

5.9

0.32

Liver

7.9

0.79*

6.6

0.62

Gall bladder

0.7

0.13

2.5

0.23

Pancreas

5.9

0.33

2.3

0.08

Larynx

7.9

0.26

2.0

0.29

Lung

32.7

0.04

14.3

0.07

Bone

3.8

0.19

1.1

0.15

Connective tissue

0.4

0.07

1.6

0.03

Melanoma of the skin

0.3

0.35

1.0

<0.01

Prostate

64.2

0.81*

  

Testis and male genitalia

0.5

0.37

  

Breast

  

137.0

0.64*

Cervix uteri

  

5.8

0.09

Corpus uteri

  

16.0

0.91*

Ovary

  

22.0

0.49*

Bladder

41.2

0.29

13.4

0.64

Kidney and urinary tract

9.4

0.65

2.2

0.02

Brain and nervous system

7.1

0.08

1.6

0.18

Thyroid

7.0

0.72*

14.7

0.92*

Hodgkin disease

4.3

0.01

4.9

0.24

Non-Hodgkin disease

22.1

0.34

20.0

0.39

All sites

296.0

0.67*

339.5

0.75*

  1. R2(R-square) values that are significant with a p-value ≤0.05 are noted with an asterisk (*), indicating a significantly fit model.